The Latest Cardiac and Vascular News
NEW YORK, Jan. 5, 2018 /PRNewswire/ — Read the full report: https://www.reportlinker.com/p04534881 The interventional cardiology devices market is expected to reach USD 20.85 billion by 2022 from USD 14.52 billion in 2017, at a CAGR of 7.5%. Factors driving the growth of this market include rising geriatric population, improving healthcare infrastructure, and increasing incidence of CVD. On the […]
Published: Jan 05, 2018 Los Angeles, California, November 26, 2017 – Advanced Bifurcation Systems announced that is it seeking $20 million in new funding from outside investors. The new goal was announced in conjunction with the appointment of new CFO Ken Richards, who brings with him a strong background in both debt […]
MARLBOROUGH, Mass., Jan. 3, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the fourth quarter ended December 31, 2017 on Thursday, February 1, 2018 at 8:00 a.m. EST. The call will be hosted by Mike Mahoney, chairman and chief executive […]
AWANS, Belgium & VIENNA–(BUSINESS WIRE)– Miracor Medical Systems GmbH (Miracor Austria) and Miracor Medical SA (Miracor Medical) today announced the closing of € 25m as part of a Series D financing round. The new capital will be used to further develop and commercialize the PiCSO®Impulse System. The round was led by Ming Capital (Shenzhen, China) […]
VANCOUVER, Jan. 2, 2018 /PRNewswire/ – Neovasc Inc. (NASDAQ, TSX:NVCN) announced today that it has received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on […]
The J.P. Morgan Healthcare Conference is held every year in early January, and this year it will be Jan. 8-11 in San Francisco, as usual. What isn’t quite as usual, and has some journalists and investors concerned, is a change in policy that limits media coverage. The meeting is a major event in […]
CHICAGO, Jan. 02, 2018 (GLOBE NEWSWIRE) — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Dr. Ravi Birla as its Chief Science Officer. Birla previously served as the Associate Director of the Department of Stem Cell Engineering […]
NEW YORK–(BUSINESS WIRE)– PAVmed (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that it intends to temporarily reduce the exercise price of the Company’s outstanding Series W Warrants (Nasdaq: PAVMW, the “Warrants”) to $2.50 per share. The Company intends to file tender offer materials (the “Offer”) […]
FRANKLIN LAKES, N.J., Dec. 22, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today’s clearance by the U.S. Federal Trade Commission (FTC) for BD to acquire C. R. Bard (NYSE: BCR), contingent on the divestitures of BD’s soft tissue core […]
MARLBOROUGH, Mass., Dec. 21, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, January 4, 2018 in Boston, MA. Mike Mahoney, chairman and chief executive officer, will participate in a 30-minute question-and-answer session with the host analyst beginning at approximately 9:30 a.m. A live webcast […]
